BioAdvance News

Yaupon Therapeutics, Inc. Secures $14.4 Million in Series D Financing

By WebmasterAugust 11, 2011November 1st, 2024No Comments

Yaupon Therapeutics, Inc. Secures $14.4 Million in Series D Financing
Read more here

Previous PostNiiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
Next PostYaupon Therapeutics, Inc. Submits New Drug Application for Proprietary Gel Formulation of Mechlorethamine Hydrochloride